Author:
Mukherjee Som D.,Coombes Megan E.,Levine Mitch,Cosby Jarold,Kowaleski Brenda,Arnold Andrew
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference37 articles.
1. DiMasi JA (1995) Trends in drug development costs, times, and risks. Drug Inf J 29:375–384
2. DiMasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22:151–185
3. Pharmaceutical Research and Manufacturers of America: Pharmaceutical Industry Profile 2006 (2006) Washington, DC
4. National Cancer Institute CTEP: Common Terminology Criteria for Adverse Events (2006) (ed Version 3.0), U.S. National Institutes of Health, Department of Health and Human Services
5. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献